The availability of a model for lentivirus immunosuppression is likely to be of critical importance in the generation and testing of an effective vaccine against HIV and AIDS. The macaque/simian immunodeficiency virus (SIV) model is perhaps the most appropriate, since it involves a lentivirus capable of induction of fatal immunodeficiency disease, and SIV is the closest known relative of HIV-l and especially HIV-2. Three of the basic problems which currently limit our understanding of immunodeficiency disease induction, the development of the SIV model, and an HIV vaccine will be addressed: (1) The in vivo biological activity of only a single molecular clone of SIV has been extensively evaluated thus far, and it appears to be minimally pathogenic in macaques, thus there is to date no adequate disease-induction system involving a molecularly defined pathogen: (2) knowledge of the features of lenti-immunodeficiency viruses responsible for their pathogenicity, and; (3) the reported high degree of genetic variation of lenti- immunodeficiency virus genomes could result in immunological escape of mutant virus in infected individuals vaccinated with a prototype inoculum of limited variability. We propose to identify and molecularly define an acute SIV pathogen starting with virus from three sources: (1) SIVsmm-PBj14, the parental strain of which induces fatal disease with survival times as short as one week: (2) SIVDelta-B670, the parental strain of which induces fatal immunodeficiency disease in 2-4 months: and (3) SIVmac-BK28, in vivo passaged from an animal which died 17 months following inoculation with this molecularly cloned and sequenced virus. We then propose to identify the viral genetic sequences responsible for disease induction by generation and testing of virus chimeras between an acute pathogen and a minimally pathogenic strain, such as SIVmac-BK28. To evaluate the rate of genome diversity we propose to inoculate macaques with molecularly cloned SIV, then monitor infected peripheral blood mononuclear cells for variation in viral genome sequence. Viral sequences will be amplified using the """"""""polymerase chain reaction"""""""", then cloned in M13 bacteriophage to determine their nucleotide sequence and, therefore, their sequence divergence. The rate of evolution of immunologically divergent epitopes will be determined in Dr. Bruck's project.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Free University of Brussels
Department
Type
DUNS #
City
Brussels
State
Country
Belgium
Zip Code
O'Neil, S P; Mossman, S P; Maul, D H et al. (1999) In vivo cell and tissue tropism of SIVsmmPBj14-bcl.3. AIDS Res Hum Retroviruses 15:203-15
O'Neil, S P; Mossman, S P; Maul, D H et al. (1999) Virus threshold determines disease in SIVsmmPBj14-infected macaques. AIDS Res Hum Retroviruses 15:183-94
Mossman, S P; Bex, F; Berglund, P et al. (1996) Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol 70:1953-60
Schwiebert, R; Fultz, P N (1994) Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events. J Virol 68:5538-47
Israel, Z R; Edmonson, P F; Maul, D H et al. (1994) Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol 68:1843-53
Fultz, P N; Zack, P M (1994) Unique lentivirus--host interactions: SIVsmmPBj14 infection of macaques. Virus Res 32:205-25
Morrow, C D; Porter, D C; Ansardi, D C et al. (1994) New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection. AIDS Res Hum Retroviruses 10 Suppl 2:S61-6
Martin, I; Dubois, M C; Defrise-Quertain, F et al. (1994) Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study. J Virol 68:1139-48
Israel, Z R; Dean, G A; Maul, D H et al. (1993) Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques. AIDS Res Hum Retroviruses 9:277-86
Martin, I; Dubois, M C; Saermark, T et al. (1993) Lysophosphatidylcholine mediates the mode of insertion of the NH2-terminal SIV fusion peptide into the lipid bilayer. FEBS Lett 333:325-30

Showing the most recent 10 out of 18 publications